Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients

The most common event responsible for resistance to first- and second-generation (1st and 2nd) epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) is acquisition of T790M mutation. We examined whether T790M is related to clinicopathologic or prognostic factors in patients with re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Matsuo, Norikazu, Azuma, Koichi, Sakai, Kazuko, Hattori, Satoshi, Kawahara, Akihiko, Ishii, Hidenobu, Tokito, Takaaki, Kinoshita, Takashi, Yamada, Kazuhiko, Nishio, Kazuto, Hoshino, Tomoaki
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5095551/
https://ncbi.nlm.nih.gov/pubmed/27811988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep36458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados